Cargando…

Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice

Pneumonia virus of mice (PVM) infection of BALB/c mice induces bronchiolitis leading to a fatal pneumonia in a dose-dependent manner, closely paralleling the development of severe disease during human respiratory syncytial virus infection in man, and is thus a recognised model in which to study the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maunder, Helen E., Taylor, Geraldine, Leppard, Keith N., Easton, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125973/ https://www.ncbi.nlm.nih.gov/pubmed/26529077 http://dx.doi.org/10.1016/j.vaccine.2015.10.105

Ejemplares similares

Intranasal Immunisation with Recombinant Toxoplasma gondii Actin Partly Protects Mice against Toxoplasmosis
por: Yin, Li-Tian, et al.
Publicado: (2013)

Intranasal immunisation with recombinant Toxoplasma gondii uridine phosphorylase confers resistance against acute toxoplasmosis in mice
por: Yin, Li-Tian, et al.
Publicado: (2023)

Generation of Cell Lines to Complement Adenovirus Vectors using Recombination-Mediated Cassette Exchange
por: Morris, Susan J, et al.
Publicado: (2010)

Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice
por: Martinez, Elisa C., et al.
Publicado: (2016)

A Novel Fiber-1-Edited and Highly Attenuated Recombinant Serotype 4 Fowl Adenovirus Confers Efficient Protection Against Lethal Challenge
por: Mu, Yaru, et al.
Publicado: (2021)

Recombinant adenovirus expressing the haemagglutinin of peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR
por: Herbert, Rebecca, et al.
Publicado: (2014)

Protective CD8(+) T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
por: Ewer, Katie J., et al.
Publicado: (2013)

An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 mice
por: Hao, Meng, et al.
Publicado: (2023)

Mucosal Immunization with Recombinant Adenovirus Encoding Soluble Globular Head of Hemagglutinin Protects Mice Against Lethal Influenza Virus Infection
por: Kim, Joo Young, et al.
Publicado: (2013)

A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
por: Bricker, Traci L., et al.
Publicado: (2021)

Single-dose Intranasal Delivery with DEF201 (Adenovirus Vectored Mouse Interferon-α) Protects Against Phlebovirus and Sars Coronavirus Challenge
por: Gowen, Brian, et al.
Publicado: (2010)

Intramammary Immunisation Provides Short Term Protection Against Mannheimia haemolytica Mastitis in Sheep
por: Tassi, Riccardo, et al.
Publicado: (2021)

A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats
por: McEachern, Jennifer A., et al.
Publicado: (2008)

The Human Adenovirus 5 L4 Promoter Is Activated by Cellular Stress Response Protein p53
por: Wright, Jordan, et al.
Publicado: (2013)

Adenovirus vectored IFN-α protects mice from lethal challenge of Chikungunya virus infection
por: Chen, Huixin, et al.
Publicado: (2020)

Human Nasal Challenge with Streptococcus pneumoniae Is Immunising in the Absence of Carriage
por: Wright, Adam K. A., et al.
Publicado: (2012)

Single-Dose Intranasal Treatment with DEF201 (Adenovirus Vectored Consensus Interferon) Prevents Lethal Disease Due to Rift Valley Fever Virus Challenge
por: Gowen, Brian B., et al.
Publicado: (2014)

Protective Immune Response against Bacillus anthracis Induced by Intranasal Introduction of a Recombinant Adenovirus Expressing the Protective Antigen Fused to the Fc-fragment of IgG2a
por: Shcherbinin, D. N., et al.
Publicado: (2014)

A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge
por: Chan, Win-Yan, et al.
Publicado: (2019)

Immunisation with ‘naïve’ syngeneic dendritic cells protects mice from tumour challenge
por: Grimshaw, M J, et al.
Publicado: (2008)

Recombinant Thrombomodulin Protects Mice against Histone-Induced Lethal Thromboembolism
por: Nakahara, Mayumi, et al.
Publicado: (2013)

Recombinant Measles Virus Vaccine Expressing the Nipah Virus Glycoprotein Protects against Lethal Nipah Virus Challenge
por: Yoneda, Misako, et al.
Publicado: (2013)

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge
por: Zhang, Fushun, et al.
Publicado: (2014)

Ribavirin Protects Syrian Hamsters against Lethal Hantavirus Pulmonary Syndrome — After Intranasal Exposure to Andes Virus
por: Ogg, Monica, et al.
Publicado: (2013)

Single dose of an adenovirus vectored mouse interferon-α protects mice from lethal EV71 challenge
por: Sun, Jialei, et al.
Publicado: (2016)

Immunisation against Measles
Publicado: (1919)

Immunisation against Diphtheria
Publicado: (1941)

A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge
por: Chiu, Fang-Feng, et al.
Publicado: (2023)

A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge
por: Parker, Scott, et al.
Publicado: (2021)

Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission
por: Ye, Chengjin, et al.
Publicado: (2023)

Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
por: Xing, Zhou, et al.
Publicado: (2009)

Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
por: Jia, Wenxu, et al.
Publicado: (2019)

Passive Immunisation against RHDV2 Induces Protection against Disease but Not Infection
por: Hall, Robyn N., et al.
Publicado: (2021)

The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K
por: Wright, Jordan, et al.
Publicado: (2015)

Multiple-Clade H5N1 Influenza Split Vaccine Elicits Broad Cross Protection against Lethal Influenza Virus Challenge in Mice by Intranasal Vaccination
por: Yang, Penghui, et al.
Publicado: (2012)

Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge
por: King, R. Glenn, et al.
Publicado: (2021)

Corrected and Republished from: “A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge”
por: Chan, Win-Yan, et al.
Publicado: (2022)

Interplay between AMA1 immunisation and parasite challenge leads to protection against malaria infection in rhesus macaques
por: Hamid, Muzamil Mahdi Abdel, et al.
Publicado: (2010)

Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
por: Munster, Vincent J., et al.
Publicado: (2017)

Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection
por: Groeger, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4kdqesmf5rgr4lbnm6huunj0lq